{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T02:36:37Z","timestamp":1788230197364,"version":"build-2803163510"},"reference-count":16,"publisher":"Japanese Society for Spine Surgery and Related Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Spine Surg Relat Res"],"published-print":{"date-parts":[[2023,3,27]]},"DOI":"10.22603\/ssrr.2022-0127","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T22:22:51Z","timestamp":1666909371000},"page":"136-141","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Outcomes of Mirogabalin Treatment for Neuropathic Pain Due to Spinal Diseases in Patients Intolerant to Continuous Administration of Pregabalin"],"prefix":"10.22603","volume":"7","author":[{"given":"Takuya","family":"Yamanaka","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, Saitama Medical Center, Jichi Medical University"},{"name":"Department of Orthopaedic Surgery, School of Medicine, Jichi Medical University"},{"name":"Department of Orthopaedic Surgery, Shinkaminokawa Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsushi","family":"Takeshita","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, School of Medicine, Jichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Mochizuki","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Saitama Medical Center, Jichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, School of Medicine, Jichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Saitama Medical Center, Jichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"9891","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Baron R, Freynhagen R, T\u00f6lle TR, et al. The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy. Pain. 2010;150 (3):420-7.","DOI":"10.1016\/j.pain.2010.04.013"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Igarashi A, Akazawa M, Murata T, et al. Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan. Clinicoecon Outcomes Res. 2015;7:505-20.","DOI":"10.2147\/CEOR.S89833"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Derry S, Bell RF, Straube S, et al. Pregabalin for neuropathic pain in adults. Cochrane Database Syst Rev. 2019;1 (1):CD007076.","DOI":"10.1002\/14651858.CD007076.pub3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shimada Y, Inage K, Orita S, et al. Effect of duloxetine on neuropathic pain in patients intolerant to continuous administration of pregabalin. Spine Surg Relate Res. 2017;1 (1):40-3.","DOI":"10.22603\/ssrr.1.2016-0012"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kimura Y, Yamaguchi S, Suzuki T, et al. Switching from pregabalin to mirogabalin in patients with peripheral neuropathic pain: a multi-center, prospective, single-arm, open-label study (MIROP Study). Pain Ther. 2021;10 (1):711-27.","DOI":"10.1007\/s40122-021-00255-y"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tetsunaga T, Tetsunaga T, Nishida K, et al. Short-term outcomes of mirogabalin in patients with peripheral neuropathic pain: a retrospective study. J Orthop Surg Res. 2020;15 (1):191.","DOI":"10.1186\/s13018-020-01709-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kim K, Isu T, Kokubo R, et al. Therapeutic effect of mirogabalin on peripheral neuropathic pain due to lumbar spine disease. Asian Spine J. 2021;15 (3):349-56.","DOI":"10.31616\/asj.2020.0136"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Akazawa T, Inoue G, Tanaka M, et al. Somnolence and dizziness during mirogabalin treatment in patients with neuropathic pain related to lumbar disease who switched from pregabalin: a retrospective study. Glob Spine J. 2021:21925682211031185.","DOI":"10.1177\/21925682211031185"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sumitani M, Sakai T, Matsuda Y, et al. Executive summary of the Clinical Guidelines of Pharmacotherapy for Neuropathic Pain: second edition by the Japanese Society of Pain Clinicians. J Anesth. 2018;32 (3):463-78.","DOI":"10.1007\/s00540-018-2501-0"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70 (18):1630-5.","DOI":"10.1212\/01.wnl.0000282763.29778.59"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Domon Y, Arakawa N, Inoue T, et al. Binding characteristics and analgesic effects of mirogabalin, a novel ligand for the \u03b12\u03b4 for the subunit of voltage-gated calcium channels. J Pharmacol Exp Ther. 2018;365 (3):573-82.","DOI":"10.1124\/jpet.117.247551"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Field MJ, Cox PJ, Stott E, et al. Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci U S A. 2006;103 (46):17537-42.","DOI":"10.1073\/pnas.0409066103"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Barclay J, Balaguero N, Mione M, et al. Ducky mouse phenotype of epilepsy and ataxia is associated with mutations in the Cacna2d2 gene and decreased calcium channel current in cerebellar Purkinje cells. J Neurosci. 2001;21 (16):6095-104.","DOI":"10.1523\/JNEUROSCI.21-16-06095.2001"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Baba M, Matsui N, Kuroha M, et al. Mirogabalin for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase III study in Asian patients. J Diabetes Investig. 2019;10 (5):1299-306.","DOI":"10.1111\/jdi.13013"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kato J, Matsui N, Kakehi Y, et al. Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients. Pain. 2019;160 (5):1175-85.","DOI":"10.1097\/j.pain.0000000000001501"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Orita S, Yamashita M, Eguchi Y, et al. Pregabalin for refractory radicular leg pain due to lumbar spinal stenosis: a preliminary prospective study. Pain Res Manag. 2016;2016:5079675.","DOI":"10.1155\/2016\/5079675"}],"container-title":["Spine Surgery and Related Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ssrr\/7\/2\/7_2022-0127\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T05:04:54Z","timestamp":1715317494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ssrr\/7\/2\/7_2022-0127\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.22603\/ssrr.2022-0127","relation":{},"ISSN":["2432-261X"],"issn-type":[{"value":"2432-261X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,27]]},"article-number":"2022-0127"}}